FAAH Antibodies

Santa Cruz Biotechnology features a diverse variety of FAAH monoclonal antibodies for the specific detection and analysis of fatty acid amide hydrolase (FAAH). FAAH monoclonal antibodies are suitable for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAAH plays a critical role in the metabolism of endocannabinoids, which are essential for regulating various physiological processes such as pain sensation, mood, and appetite. By hydrolyzing fatty acid amides, including anandamide, FAAH influences the endocannabinoid system and has been implicated in several neurological and inflammatory disorders. Understanding FAAH function is crucial for developing therapeutic strategies targeting endocannabinoid pathways. Research has shown that FAAH activity significantly impacts neurotransmitter signaling and inflammatory responses. Investigating FAAH expression patterns helps reveal its involvement in various cellular processes and disease mechanisms. Current studies focusing on FAAH continue to uncover new aspects of endocannabinoid regulation and its therapeutic potential. Santa Cruz Biotechnology monoclonal antibodies targeting FAAH enable researchers to advance their understanding of endocannabinoid system biology and contribute to the development of novel therapeutic approaches.